ERCC2/XPD gene polymorphisms and cancer risk.

Area of Science:

• Genetics
• Molecular Biology
• Cancer Research

Background:

• DNA repair is crucial for preventing diseases like xeroderma pigmentosum (XP), characterized by DNA repair deficiency and high cancer susceptibility.
• Subtle variations in DNA repair efficiency within the general population could contribute to cancer development, especially in individuals exposed to carcinogens.

Purpose of the Study:

• To investigate the association between single nucleotide polymorphisms (SNPs) in key DNA repair genes and common human cancers.
• To review epidemiological studies on XPD (ERCC2) gene polymorphisms and their correlation with DNA repair efficiency, cancer development, and environmental interactions.

Main Methods:

• Focus on three specific SNPs in the ERCC2/XPD gene: exon 6 (silent), exon 10 (Asp312Asn), and exon 23 (Lys751Gln).
• Analysis of epidemiological studies assessing DNA repair efficiency using various assays.
• Examination of correlations with cutaneous carcinomas and smoking-related cancers.

Main Results:

• The review synthesizes findings on whether these XPD polymorphisms are linked to reduced DNA repair capacity.
• Investigates the influence of these polymorphisms on the risk of developing specific cancers.
• Explores potential interactions between XPD gene variants and environmental exposures, such as smoking.

Conclusions:

• XPD protein plays a significant role in DNA repair, transcription, cell cycle control, and apoptosis.
• Specific XPD gene polymorphisms may modulate DNA repair efficiency and influence cancer susceptibility.
• Further research is warranted to understand the interplay between genetic variations, DNA repair, and environmental factors in cancer etiology.